nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Epirubicin—stomach cancer	0.227	0.519	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—stomach cancer	0.21	0.481	CiPCiCtD
Irinotecan—colon cancer—stomach cancer	0.164	0.569	CtDrD
Irinotecan—pancreatic cancer—stomach cancer	0.124	0.431	CtDrD
Irinotecan—CES1—Capecitabine—stomach cancer	0.042	0.285	CbGbCtD
Irinotecan—ALB—stomach cancer	0.0295	1	CbGaD
Irinotecan—ABCC1—Epirubicin—stomach cancer	0.0109	0.0737	CbGbCtD
Irinotecan—ABCB1—Mitomycin—stomach cancer	0.00995	0.0675	CbGbCtD
Irinotecan—ABCC1—Docetaxel—stomach cancer	0.00776	0.0526	CbGbCtD
Irinotecan—ABCG2—Fluorouracil—stomach cancer	0.0068	0.0461	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—stomach cancer	0.00578	0.0392	CbGbCtD
Irinotecan—ABCC2—Docetaxel—stomach cancer	0.00574	0.0389	CbGbCtD
Irinotecan—ABCC1—Methotrexate—stomach cancer	0.0056	0.038	CbGbCtD
Irinotecan—ABCG2—Docetaxel—stomach cancer	0.00519	0.0352	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—stomach cancer	0.00472	0.032	CbGbCtD
Irinotecan—ALB—Fluorouracil—stomach cancer	0.00469	0.0318	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—stomach cancer	0.00428	0.029	CbGbCtD
Irinotecan—ABCC2—Methotrexate—stomach cancer	0.00415	0.0281	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—stomach cancer	0.00387	0.0262	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.00383	0.026	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—stomach cancer	0.00383	0.026	CbGbCtD
Irinotecan—ABCG2—Methotrexate—stomach cancer	0.00375	0.0254	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—stomach cancer	0.00288	0.0195	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—stomach cancer	0.00272	0.0184	CbGbCtD
Irinotecan—ALB—Methotrexate—stomach cancer	0.00258	0.0175	CbGbCtD
Irinotecan—ABCB1—Docetaxel—stomach cancer	0.00187	0.0127	CbGbCtD
Irinotecan—BCHE—diaphragm—stomach cancer	0.00149	0.0859	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—stomach cancer	0.0014	0.00946	CbGbCtD
Irinotecan—ABCB1—Methotrexate—stomach cancer	0.00135	0.00916	CbGbCtD
Irinotecan—ABCC2—bile—stomach cancer	0.00132	0.0757	CbGeAlD
Irinotecan—CYP3A4—Docetaxel—stomach cancer	0.00112	0.0076	CbGbCtD
Irinotecan—CYP3A4—Doxorubicin—stomach cancer	0.000836	0.00567	CbGbCtD
Irinotecan—CES1—gall bladder—stomach cancer	0.000561	0.0322	CbGeAlD
Irinotecan—TOP1MT—endocrine gland—stomach cancer	0.000463	0.0266	CbGeAlD
Irinotecan—TOP1MT—liver—stomach cancer	0.000417	0.024	CbGeAlD
Irinotecan—ALB—gall bladder—stomach cancer	0.00039	0.0224	CbGeAlD
Irinotecan—CES2—hematopoietic system—stomach cancer	0.000386	0.0222	CbGeAlD
Irinotecan—TOP1—smooth muscle tissue—stomach cancer	0.000374	0.0215	CbGeAlD
Irinotecan—TOP1—pancreas—stomach cancer	0.000346	0.0199	CbGeAlD
Irinotecan—CES2—smooth muscle tissue—stomach cancer	0.00034	0.0195	CbGeAlD
Irinotecan—UGT1A9—digestive system—stomach cancer	0.000333	0.0191	CbGeAlD
Irinotecan—UGT1A1—hematopoietic system—stomach cancer	0.000328	0.0188	CbGeAlD
Irinotecan—TOP1MT—lymph node—stomach cancer	0.00032	0.0184	CbGeAlD
Irinotecan—CES1—hematopoietic system—stomach cancer	0.000317	0.0183	CbGeAlD
Irinotecan—CES2—pancreas—stomach cancer	0.000314	0.018	CbGeAlD
Irinotecan—UGT1A9—endocrine gland—stomach cancer	0.000275	0.0158	CbGeAlD
Irinotecan—SLCO1B1—hematopoietic system—stomach cancer	0.000273	0.0157	CbGeAlD
Irinotecan—TOP1—bone marrow—stomach cancer	0.000272	0.0157	CbGeAlD
Irinotecan—CES2—digestive system—stomach cancer	0.000268	0.0154	CbGeAlD
Irinotecan—UGT1A9—liver—stomach cancer	0.000248	0.0142	CbGeAlD
Irinotecan—CES2—bone marrow—stomach cancer	0.000247	0.0142	CbGeAlD
Irinotecan—CYP3A7—endocrine gland—stomach cancer	0.000229	0.0131	CbGeAlD
Irinotecan—UGT1A1—digestive system—stomach cancer	0.000228	0.0131	CbGeAlD
Irinotecan—CES1—lymphoid tissue—stomach cancer	0.000224	0.0128	CbGeAlD
Irinotecan—CES2—endocrine gland—stomach cancer	0.000222	0.0127	CbGeAlD
Irinotecan—CES1—digestive system—stomach cancer	0.000221	0.0127	CbGeAlD
Irinotecan—SLC22A3—hematopoietic system—stomach cancer	0.00022	0.0127	CbGeAlD
Irinotecan—TOP1—liver—stomach cancer	0.00022	0.0127	CbGeAlD
Irinotecan—CYP3A7—liver—stomach cancer	0.000206	0.0118	CbGeAlD
Irinotecan—CES2—liver—stomach cancer	0.0002	0.0115	CbGeAlD
Irinotecan—SLC22A3—smooth muscle tissue—stomach cancer	0.000194	0.0112	CbGeAlD
Irinotecan—SLCO1B1—digestive system—stomach cancer	0.00019	0.0109	CbGeAlD
Irinotecan—UGT1A1—endocrine gland—stomach cancer	0.000188	0.0108	CbGeAlD
Irinotecan—CES1—endocrine gland—stomach cancer	0.000182	0.0105	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—liver—stomach cancer	0.000175	0.0101	CbGeAlD
Irinotecan—UGT1A1—liver—stomach cancer	0.00017	0.00976	CbGeAlD
Irinotecan—TOP1—lymph node—stomach cancer	0.000169	0.00971	CbGeAlD
Irinotecan—CES1—liver—stomach cancer	0.000164	0.00946	CbGeAlD
Irinotecan—SLCO1B1—endocrine gland—stomach cancer	0.000157	0.00901	CbGeAlD
Irinotecan—BCHE—hematopoietic system—stomach cancer	0.000156	0.00897	CbGeAlD
Irinotecan—CES2—lymph node—stomach cancer	0.000153	0.0088	CbGeAlD
Irinotecan—ABCC2—digestive system—stomach cancer	0.000144	0.00827	CbGeAlD
Irinotecan—SLCO1B1—liver—stomach cancer	0.000141	0.00812	CbGeAlD
Irinotecan—CYP3A5—hematopoietic system—stomach cancer	0.00014	0.00805	CbGeAlD
Irinotecan—ABCB1—blood vessel—stomach cancer	0.00014	0.00803	CbGeAlD
Irinotecan—CYP2B6—hematopoietic system—stomach cancer	0.000139	0.008	CbGeAlD
Irinotecan—BCHE—smooth muscle tissue—stomach cancer	0.000137	0.0079	CbGeAlD
Irinotecan—SLC22A3—endocrine gland—stomach cancer	0.000127	0.00728	CbGeAlD
Irinotecan—ACHE—lymph node—stomach cancer	0.000126	0.00725	CbGeAlD
Irinotecan—CES1—lymph node—stomach cancer	0.000126	0.00725	CbGeAlD
Irinotecan—ABCC2—endocrine gland—stomach cancer	0.000119	0.00683	CbGeAlD
Irinotecan—ALB—liver—stomach cancer	0.000114	0.00657	CbGeAlD
Irinotecan—SLC22A3—liver—stomach cancer	0.000114	0.00656	CbGeAlD
Irinotecan—CYP3A5—pancreas—stomach cancer	0.000114	0.00655	CbGeAlD
Irinotecan—BCHE—digestive system—stomach cancer	0.000109	0.00624	CbGeAlD
Irinotecan—ABCC2—liver—stomach cancer	0.000107	0.00616	CbGeAlD
Irinotecan—CYP3A4—hematopoietic system—stomach cancer	0.000105	0.00604	CbGeAlD
Irinotecan—BCHE—bone marrow—stomach cancer	0.0001	0.00575	CbGeAlD
Irinotecan—CYP2B6—lymphoid tissue—stomach cancer	9.79e-05	0.00563	CbGeAlD
Irinotecan—CYP3A5—digestive system—stomach cancer	9.73e-05	0.0056	CbGeAlD
Irinotecan—CYP2B6—digestive system—stomach cancer	9.67e-05	0.00556	CbGeAlD
Irinotecan—ABCG2—bone marrow—stomach cancer	9.67e-05	0.00556	CbGeAlD
Irinotecan—ABCC1—liver—stomach cancer	9.44e-05	0.00543	CbGeAlD
Irinotecan—BCHE—endocrine gland—stomach cancer	8.97e-05	0.00515	CbGeAlD
Irinotecan—ALB—lymph node—stomach cancer	8.77e-05	0.00504	CbGeAlD
Irinotecan—SLC22A3—lymph node—stomach cancer	8.75e-05	0.00503	CbGeAlD
Irinotecan—ABCC2—lymph node—stomach cancer	8.21e-05	0.00472	CbGeAlD
Irinotecan—BCHE—liver—stomach cancer	8.08e-05	0.00465	CbGeAlD
Irinotecan—CYP3A5—endocrine gland—stomach cancer	8.04e-05	0.00462	CbGeAlD
Irinotecan—CYP2B6—endocrine gland—stomach cancer	7.99e-05	0.0046	CbGeAlD
Irinotecan—ABCG2—liver—stomach cancer	7.81e-05	0.00449	CbGeAlD
Irinotecan—ABCB1—hematopoietic system—stomach cancer	7.44e-05	0.00427	CbGeAlD
Irinotecan—CYP3A4—digestive system—stomach cancer	7.31e-05	0.0042	CbGeAlD
Irinotecan—CYP3A5—liver—stomach cancer	7.25e-05	0.00417	CbGeAlD
Irinotecan—ABCC1—lymph node—stomach cancer	7.24e-05	0.00416	CbGeAlD
Irinotecan—CYP2B6—liver—stomach cancer	7.21e-05	0.00414	CbGeAlD
Irinotecan—ABCB1—epithelium—stomach cancer	6.8e-05	0.00391	CbGeAlD
Irinotecan—BCHE—lymph node—stomach cancer	6.2e-05	0.00356	CbGeAlD
Irinotecan—ABCB1—pancreas—stomach cancer	6.05e-05	0.00348	CbGeAlD
Irinotecan—CYP3A4—endocrine gland—stomach cancer	6.04e-05	0.00347	CbGeAlD
Irinotecan—ABCG2—lymph node—stomach cancer	5.99e-05	0.00344	CbGeAlD
Irinotecan—CYP3A4—liver—stomach cancer	5.44e-05	0.00313	CbGeAlD
Irinotecan—ABCB1—lymphoid tissue—stomach cancer	5.24e-05	0.00301	CbGeAlD
Irinotecan—ABCB1—digestive system—stomach cancer	5.17e-05	0.00297	CbGeAlD
Irinotecan—ABCB1—bone marrow—stomach cancer	4.77e-05	0.00274	CbGeAlD
Irinotecan—ABCB1—endocrine gland—stomach cancer	4.27e-05	0.00246	CbGeAlD
Irinotecan—ABCB1—liver—stomach cancer	3.85e-05	0.00221	CbGeAlD
Irinotecan—ABCB1—lymph node—stomach cancer	2.95e-05	0.0017	CbGeAlD
Irinotecan—Jaundice—Epirubicin—stomach cancer	2.83e-05	0.000538	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—stomach cancer	2.82e-05	0.000535	CcSEcCtD
Irinotecan—Hypertension—Capecitabine—stomach cancer	2.81e-05	0.000534	CcSEcCtD
Irinotecan—Hypersensitivity—Fluorouracil—stomach cancer	2.8e-05	0.000532	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—stomach cancer	2.8e-05	0.000532	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—stomach cancer	2.8e-05	0.000532	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—stomach cancer	2.79e-05	0.000529	CcSEcCtD
Irinotecan—Sweating—Epirubicin—stomach cancer	2.78e-05	0.000529	CcSEcCtD
Irinotecan—Confusional state—Docetaxel—stomach cancer	2.77e-05	0.000526	CcSEcCtD
Irinotecan—Oedema—Docetaxel—stomach cancer	2.75e-05	0.000522	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—stomach cancer	2.75e-05	0.000522	CcSEcCtD
Irinotecan—Discomfort—Capecitabine—stomach cancer	2.74e-05	0.00052	CcSEcCtD
Irinotecan—Infection—Docetaxel—stomach cancer	2.73e-05	0.000518	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—stomach cancer	2.73e-05	0.000518	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—stomach cancer	2.7e-05	0.000513	CcSEcCtD
Irinotecan—Shock—Docetaxel—stomach cancer	2.7e-05	0.000513	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—stomach cancer	2.69e-05	0.000511	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—stomach cancer	2.69e-05	0.000511	CcSEcCtD
Irinotecan—Visual impairment—Methotrexate—stomach cancer	2.68e-05	0.00051	CcSEcCtD
Irinotecan—Confusional state—Capecitabine—stomach cancer	2.68e-05	0.000509	CcSEcCtD
Irinotecan—Oedema—Capecitabine—stomach cancer	2.66e-05	0.000505	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—stomach cancer	2.65e-05	0.000504	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—stomach cancer	2.64e-05	0.000502	CcSEcCtD
Irinotecan—Infection—Capecitabine—stomach cancer	2.64e-05	0.000502	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—stomach cancer	2.62e-05	0.000498	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—stomach cancer	2.62e-05	0.000497	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—stomach cancer	2.62e-05	0.000497	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—stomach cancer	2.62e-05	0.000497	CcSEcCtD
Irinotecan—Shock—Capecitabine—stomach cancer	2.62e-05	0.000497	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—stomach cancer	2.61e-05	0.000496	CcSEcCtD
Irinotecan—Nervous system disorder—Capecitabine—stomach cancer	2.61e-05	0.000495	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—stomach cancer	2.61e-05	0.000495	CcSEcCtD
Irinotecan—Diarrhoea—Fluorouracil—stomach cancer	2.6e-05	0.000494	CcSEcCtD
Irinotecan—Thrombocytopenia—Capecitabine—stomach cancer	2.6e-05	0.000494	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—stomach cancer	2.58e-05	0.000491	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—stomach cancer	2.58e-05	0.000489	CcSEcCtD
Irinotecan—Hyperhidrosis—Capecitabine—stomach cancer	2.57e-05	0.000488	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—stomach cancer	2.57e-05	0.000487	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—stomach cancer	2.56e-05	0.000487	CcSEcCtD
Irinotecan—Anorexia—Capecitabine—stomach cancer	2.53e-05	0.000481	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—stomach cancer	2.53e-05	0.00048	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—stomach cancer	2.52e-05	0.000478	CcSEcCtD
Irinotecan—Dizziness—Fluorouracil—stomach cancer	2.52e-05	0.000478	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—stomach cancer	2.51e-05	0.000477	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—stomach cancer	2.51e-05	0.000477	CcSEcCtD
Irinotecan—Chills—Methotrexate—stomach cancer	2.5e-05	0.000475	CcSEcCtD
Irinotecan—Hypotension—Capecitabine—stomach cancer	2.48e-05	0.000472	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—stomach cancer	2.48e-05	0.000472	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—stomach cancer	2.47e-05	0.000468	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—stomach cancer	2.46e-05	0.000468	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—stomach cancer	2.46e-05	0.000466	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—stomach cancer	2.45e-05	0.000465	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—stomach cancer	2.44e-05	0.000464	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—stomach cancer	2.42e-05	0.00046	CcSEcCtD
Irinotecan—Flushing—Epirubicin—stomach cancer	2.42e-05	0.00046	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—stomach cancer	2.42e-05	0.00046	CcSEcCtD
Irinotecan—Vomiting—Fluorouracil—stomach cancer	2.42e-05	0.000459	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—stomach cancer	2.42e-05	0.000459	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—stomach cancer	2.42e-05	0.000459	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—stomach cancer	2.41e-05	0.000458	CcSEcCtD
Irinotecan—Insomnia—Capecitabine—stomach cancer	2.4e-05	0.000457	CcSEcCtD
Irinotecan—Rash—Fluorouracil—stomach cancer	2.4e-05	0.000456	CcSEcCtD
Irinotecan—Dermatitis—Fluorouracil—stomach cancer	2.4e-05	0.000455	CcSEcCtD
Irinotecan—Paraesthesia—Capecitabine—stomach cancer	2.39e-05	0.000453	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—stomach cancer	2.39e-05	0.000453	CcSEcCtD
Irinotecan—Headache—Fluorouracil—stomach cancer	2.38e-05	0.000453	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—stomach cancer	2.37e-05	0.00045	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—stomach cancer	2.37e-05	0.00045	CcSEcCtD
Irinotecan—Dyspnoea—Capecitabine—stomach cancer	2.37e-05	0.00045	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—stomach cancer	2.37e-05	0.00045	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—stomach cancer	2.36e-05	0.000449	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—stomach cancer	2.35e-05	0.000447	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—stomach cancer	2.35e-05	0.000446	CcSEcCtD
Irinotecan—Pain—Docetaxel—stomach cancer	2.35e-05	0.000446	CcSEcCtD
Irinotecan—Constipation—Docetaxel—stomach cancer	2.35e-05	0.000446	CcSEcCtD
Irinotecan—Back pain—Methotrexate—stomach cancer	2.35e-05	0.000446	CcSEcCtD
Irinotecan—Dyspepsia—Capecitabine—stomach cancer	2.34e-05	0.000444	CcSEcCtD
Irinotecan—Chills—Epirubicin—stomach cancer	2.34e-05	0.000444	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—stomach cancer	2.33e-05	0.000442	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—stomach cancer	2.32e-05	0.000441	CcSEcCtD
Irinotecan—Decreased appetite—Capecitabine—stomach cancer	2.31e-05	0.000439	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—stomach cancer	2.3e-05	0.000438	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Capecitabine—stomach cancer	2.29e-05	0.000436	CcSEcCtD
Irinotecan—Fatigue—Capecitabine—stomach cancer	2.29e-05	0.000435	CcSEcCtD
Irinotecan—Pain—Capecitabine—stomach cancer	2.27e-05	0.000432	CcSEcCtD
Irinotecan—Constipation—Capecitabine—stomach cancer	2.27e-05	0.000432	CcSEcCtD
Irinotecan—Feeling abnormal—Docetaxel—stomach cancer	2.26e-05	0.00043	CcSEcCtD
Irinotecan—Nausea—Fluorouracil—stomach cancer	2.26e-05	0.000429	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—stomach cancer	2.25e-05	0.000427	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—stomach cancer	2.25e-05	0.000426	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—stomach cancer	2.24e-05	0.000426	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—stomach cancer	2.24e-05	0.000425	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—stomach cancer	2.24e-05	0.000425	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—stomach cancer	2.24e-05	0.000425	CcSEcCtD
Irinotecan—Back pain—Epirubicin—stomach cancer	2.19e-05	0.000417	CcSEcCtD
Irinotecan—Feeling abnormal—Capecitabine—stomach cancer	2.19e-05	0.000416	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—stomach cancer	2.19e-05	0.000416	CcSEcCtD
Irinotecan—Malaise—Methotrexate—stomach cancer	2.19e-05	0.000415	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—stomach cancer	2.18e-05	0.000414	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—stomach cancer	2.18e-05	0.000414	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—stomach cancer	2.18e-05	0.000414	CcSEcCtD
Irinotecan—Gastrointestinal pain—Capecitabine—stomach cancer	2.17e-05	0.000413	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—stomach cancer	2.17e-05	0.000413	CcSEcCtD
Irinotecan—Abdominal pain—Docetaxel—stomach cancer	2.17e-05	0.000412	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—stomach cancer	2.17e-05	0.000412	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—stomach cancer	2.17e-05	0.000412	CcSEcCtD
Irinotecan—Chills—Doxorubicin—stomach cancer	2.16e-05	0.000411	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—stomach cancer	2.15e-05	0.000409	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—stomach cancer	2.13e-05	0.000405	CcSEcCtD
Irinotecan—Cough—Methotrexate—stomach cancer	2.12e-05	0.000402	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—stomach cancer	2.11e-05	0.0004	CcSEcCtD
Irinotecan—Abdominal pain—Capecitabine—stomach cancer	2.1e-05	0.000399	CcSEcCtD
Irinotecan—Body temperature increased—Capecitabine—stomach cancer	2.1e-05	0.000399	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—stomach cancer	2.1e-05	0.000398	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—stomach cancer	2.07e-05	0.000393	CcSEcCtD
Irinotecan—Malaise—Epirubicin—stomach cancer	2.05e-05	0.000389	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—stomach cancer	2.04e-05	0.000387	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—stomach cancer	2.04e-05	0.000387	CcSEcCtD
Irinotecan—Syncope—Epirubicin—stomach cancer	2.03e-05	0.000387	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—stomach cancer	2.03e-05	0.000386	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—stomach cancer	2.03e-05	0.000386	CcSEcCtD
Irinotecan—Hypersensitivity—Docetaxel—stomach cancer	2.02e-05	0.000384	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—stomach cancer	2.02e-05	0.000383	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—stomach cancer	2e-05	0.000379	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—stomach cancer	1.99e-05	0.000379	CcSEcCtD
Irinotecan—Cough—Epirubicin—stomach cancer	1.98e-05	0.000376	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—stomach cancer	1.98e-05	0.000376	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—stomach cancer	1.97e-05	0.000374	CcSEcCtD
Irinotecan—Infection—Methotrexate—stomach cancer	1.97e-05	0.000373	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—stomach cancer	1.96e-05	0.000372	CcSEcCtD
Irinotecan—Hypersensitivity—Capecitabine—stomach cancer	1.96e-05	0.000372	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—stomach cancer	1.95e-05	0.00037	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—stomach cancer	1.94e-05	0.000369	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—stomach cancer	1.94e-05	0.000369	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—stomach cancer	1.94e-05	0.000368	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—stomach cancer	1.91e-05	0.000363	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—stomach cancer	1.91e-05	0.000363	CcSEcCtD
Irinotecan—Asthenia—Capecitabine—stomach cancer	1.91e-05	0.000362	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—stomach cancer	1.89e-05	0.00036	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—stomach cancer	1.89e-05	0.000358	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—stomach cancer	1.89e-05	0.000358	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—stomach cancer	1.88e-05	0.000358	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—stomach cancer	1.88e-05	0.000357	CcSEcCtD
Irinotecan—Diarrhoea—Docetaxel—stomach cancer	1.88e-05	0.000357	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—stomach cancer	1.87e-05	0.000355	CcSEcCtD
Irinotecan—Oedema—Epirubicin—stomach cancer	1.85e-05	0.000352	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—stomach cancer	1.85e-05	0.000352	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—stomach cancer	1.85e-05	0.000351	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—stomach cancer	1.85e-05	0.000351	CcSEcCtD
Irinotecan—Infection—Epirubicin—stomach cancer	1.84e-05	0.000349	CcSEcCtD
Irinotecan—Cough—Doxorubicin—stomach cancer	1.83e-05	0.000348	CcSEcCtD
Irinotecan—Shock—Epirubicin—stomach cancer	1.82e-05	0.000346	CcSEcCtD
Irinotecan—Diarrhoea—Capecitabine—stomach cancer	1.82e-05	0.000345	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—stomach cancer	1.82e-05	0.000345	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—stomach cancer	1.82e-05	0.000345	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—stomach cancer	1.81e-05	0.000344	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—stomach cancer	1.81e-05	0.000344	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—stomach cancer	1.79e-05	0.00034	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—stomach cancer	1.79e-05	0.00034	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—stomach cancer	1.78e-05	0.000338	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—stomach cancer	1.77e-05	0.000335	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—stomach cancer	1.77e-05	0.000335	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—stomach cancer	1.76e-05	0.000335	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—stomach cancer	1.76e-05	0.000334	CcSEcCtD
Irinotecan—Dizziness—Capecitabine—stomach cancer	1.76e-05	0.000334	CcSEcCtD
Irinotecan—Vomiting—Docetaxel—stomach cancer	1.75e-05	0.000332	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—stomach cancer	1.74e-05	0.000331	CcSEcCtD
Irinotecan—Rash—Docetaxel—stomach cancer	1.73e-05	0.000329	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—stomach cancer	1.73e-05	0.000329	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—stomach cancer	1.73e-05	0.000329	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—stomach cancer	1.73e-05	0.000328	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—stomach cancer	1.72e-05	0.000327	CcSEcCtD
Irinotecan—Headache—Docetaxel—stomach cancer	1.72e-05	0.000327	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—stomach cancer	1.71e-05	0.000325	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—stomach cancer	1.71e-05	0.000325	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—stomach cancer	1.71e-05	0.000325	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—stomach cancer	1.71e-05	0.000324	CcSEcCtD
Irinotecan—Infection—Doxorubicin—stomach cancer	1.7e-05	0.000323	CcSEcCtD
Irinotecan—Pain—Methotrexate—stomach cancer	1.69e-05	0.000321	CcSEcCtD
Irinotecan—Vomiting—Capecitabine—stomach cancer	1.69e-05	0.000321	CcSEcCtD
Irinotecan—Shock—Doxorubicin—stomach cancer	1.69e-05	0.00032	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—stomach cancer	1.68e-05	0.000319	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—stomach cancer	1.68e-05	0.000319	CcSEcCtD
Irinotecan—Rash—Capecitabine—stomach cancer	1.68e-05	0.000318	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—stomach cancer	1.67e-05	0.000318	CcSEcCtD
Irinotecan—Dermatitis—Capecitabine—stomach cancer	1.67e-05	0.000318	CcSEcCtD
Irinotecan—Headache—Capecitabine—stomach cancer	1.67e-05	0.000316	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—stomach cancer	1.66e-05	0.000316	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—stomach cancer	1.66e-05	0.000315	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—stomach cancer	1.65e-05	0.000314	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—stomach cancer	1.65e-05	0.000313	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—stomach cancer	1.63e-05	0.00031	CcSEcCtD
Irinotecan—Nausea—Docetaxel—stomach cancer	1.63e-05	0.00031	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—stomach cancer	1.63e-05	0.00031	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—stomach cancer	1.63e-05	0.00031	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—stomach cancer	1.62e-05	0.000307	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—stomach cancer	1.61e-05	0.000306	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—stomach cancer	1.6e-05	0.000304	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—stomach cancer	1.6e-05	0.000304	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—stomach cancer	1.6e-05	0.000303	CcSEcCtD
Irinotecan—Constipation—Epirubicin—stomach cancer	1.58e-05	0.000301	CcSEcCtD
Irinotecan—Pain—Epirubicin—stomach cancer	1.58e-05	0.000301	CcSEcCtD
Irinotecan—Nausea—Capecitabine—stomach cancer	1.58e-05	0.0003	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—stomach cancer	1.56e-05	0.000297	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—stomach cancer	1.56e-05	0.000297	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—stomach cancer	1.55e-05	0.000294	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—stomach cancer	1.54e-05	0.000292	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—stomach cancer	1.53e-05	0.00029	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—stomach cancer	1.53e-05	0.00029	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—stomach cancer	1.52e-05	0.000289	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—stomach cancer	1.51e-05	0.000288	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—stomach cancer	1.51e-05	0.000287	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—stomach cancer	1.49e-05	0.000283	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—stomach cancer	1.48e-05	0.000281	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—stomach cancer	1.48e-05	0.000281	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—stomach cancer	1.47e-05	0.000278	CcSEcCtD
Irinotecan—Pain—Doxorubicin—stomach cancer	1.47e-05	0.000278	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—stomach cancer	1.46e-05	0.000278	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—stomach cancer	1.46e-05	0.000278	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—stomach cancer	1.46e-05	0.000277	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—stomach cancer	1.42e-05	0.00027	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—stomach cancer	1.41e-05	0.000268	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—stomach cancer	1.4e-05	0.000266	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—stomach cancer	1.36e-05	0.000259	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—stomach cancer	1.35e-05	0.000257	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—stomach cancer	1.35e-05	0.000257	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—stomach cancer	1.35e-05	0.000257	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—stomach cancer	1.33e-05	0.000252	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—stomach cancer	1.31e-05	0.000249	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—stomach cancer	1.27e-05	0.000241	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—stomach cancer	1.26e-05	0.00024	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—stomach cancer	1.26e-05	0.000239	CcSEcCtD
Irinotecan—Rash—Methotrexate—stomach cancer	1.25e-05	0.000237	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—stomach cancer	1.25e-05	0.000237	CcSEcCtD
Irinotecan—Headache—Methotrexate—stomach cancer	1.24e-05	0.000235	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—stomach cancer	1.23e-05	0.000234	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—stomach cancer	1.22e-05	0.000233	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—stomach cancer	1.18e-05	0.000224	CcSEcCtD
Irinotecan—Nausea—Methotrexate—stomach cancer	1.18e-05	0.000223	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—stomach cancer	1.17e-05	0.000223	CcSEcCtD
Irinotecan—Rash—Epirubicin—stomach cancer	1.17e-05	0.000222	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—stomach cancer	1.17e-05	0.000222	CcSEcCtD
Irinotecan—Headache—Epirubicin—stomach cancer	1.16e-05	0.00022	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—stomach cancer	1.13e-05	0.000215	CcSEcCtD
Irinotecan—Nausea—Epirubicin—stomach cancer	1.1e-05	0.000209	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—stomach cancer	1.09e-05	0.000207	CcSEcCtD
Irinotecan—Rash—Doxorubicin—stomach cancer	1.08e-05	0.000205	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—stomach cancer	1.08e-05	0.000205	CcSEcCtD
Irinotecan—Headache—Doxorubicin—stomach cancer	1.07e-05	0.000204	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—stomach cancer	1.02e-05	0.000193	CcSEcCtD
Irinotecan—CYP3A5—Metabolism—CYP2A6—stomach cancer	2.1e-06	7.7e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPP2R1A—stomach cancer	2.1e-06	7.68e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ERCC2—stomach cancer	2.09e-06	7.67e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTM1—stomach cancer	2.09e-06	7.67e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ERCC2—stomach cancer	2.09e-06	7.67e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKR1C3—stomach cancer	2.09e-06	7.66e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.09e-06	7.66e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CAV1—stomach cancer	2.09e-06	7.66e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APOA1—stomach cancer	2.08e-06	7.64e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPP2R1A—stomach cancer	2.08e-06	7.62e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—MTHFR—stomach cancer	2.07e-06	7.6e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.07e-06	7.6e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—DPYD—stomach cancer	2.07e-06	7.59e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TYMS—stomach cancer	2.06e-06	7.57e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTP1—stomach cancer	2.06e-06	7.54e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKR1C3—stomach cancer	2.04e-06	7.49e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTM1—stomach cancer	2.04e-06	7.48e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTP1—stomach cancer	2.04e-06	7.47e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ENO1—stomach cancer	2.04e-06	7.47e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—HMOX1—stomach cancer	2.03e-06	7.43e-05	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	2.02e-06	7.42e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ERCC2—stomach cancer	2.02e-06	7.4e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—HMOX1—stomach cancer	2.01e-06	7.37e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ENO1—stomach cancer	1.99e-06	7.3e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALDOB—stomach cancer	1.98e-06	7.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6ST—stomach cancer	1.98e-06	7.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.98e-06	7.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FBP1—stomach cancer	1.98e-06	7.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CKB—stomach cancer	1.98e-06	7.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA1—stomach cancer	1.98e-06	7.25e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ERCC2—stomach cancer	1.97e-06	7.22e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—MTHFR—stomach cancer	1.97e-06	7.21e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—MTHFR—stomach cancer	1.97e-06	7.21e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.93e-06	7.09e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ALB—stomach cancer	1.92e-06	7.04e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.92e-06	7.03e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CAV1—stomach cancer	1.91e-06	7.01e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TYMS—stomach cancer	1.91e-06	7.01e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—APOA1—stomach cancer	1.91e-06	7e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.9e-06	6.98e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—stomach cancer	1.9e-06	6.98e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—MTHFR—stomach cancer	1.9e-06	6.96e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TYMS—stomach cancer	1.89e-06	6.94e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTM1—stomach cancer	1.89e-06	6.93e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.88e-06	6.88e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTM1—stomach cancer	1.87e-06	6.86e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLIN2—stomach cancer	1.86e-06	6.82e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SERPINE1—stomach cancer	1.86e-06	6.81e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—MTHFR—stomach cancer	1.85e-06	6.78e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALOX5—stomach cancer	1.84e-06	6.76e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.84e-06	6.76e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—NOS3—stomach cancer	1.84e-06	6.74e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTT1—stomach cancer	1.83e-06	6.71e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.83e-06	6.7e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CAV1—stomach cancer	1.81e-06	6.65e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CAV1—stomach cancer	1.81e-06	6.65e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—DPYD—stomach cancer	1.81e-06	6.65e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—APOA1—stomach cancer	1.81e-06	6.64e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—APOA1—stomach cancer	1.81e-06	6.64e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP2A6—stomach cancer	1.81e-06	6.63e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA2—stomach cancer	1.81e-06	6.63e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CD44—stomach cancer	1.81e-06	6.62e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.8e-06	6.61e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RHOA—stomach cancer	1.79e-06	6.56e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ERCC2—stomach cancer	1.78e-06	6.51e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.77e-06	6.5e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NOS3—stomach cancer	1.77e-06	6.5e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6R—stomach cancer	1.77e-06	6.48e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CD44—stomach cancer	1.77e-06	6.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NT5E—stomach cancer	1.76e-06	6.46e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PGAM1—stomach cancer	1.76e-06	6.46e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ERCC2—stomach cancer	1.76e-06	6.45e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKR1C3—stomach cancer	1.76e-06	6.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CAV1—stomach cancer	1.75e-06	6.42e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—APOA1—stomach cancer	1.75e-06	6.4e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.73e-06	6.36e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ENO1—stomach cancer	1.71e-06	6.29e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CAV1—stomach cancer	1.71e-06	6.26e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—APOA1—stomach cancer	1.7e-06	6.24e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PPARG—stomach cancer	1.68e-06	6.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.68e-06	6.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLCE1—stomach cancer	1.68e-06	6.16e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—stomach cancer	1.68e-06	6.16e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.67e-06	6.13e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—MTHFR—stomach cancer	1.67e-06	6.12e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CAV1—stomach cancer	1.66e-06	6.1e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—APOA1—stomach cancer	1.66e-06	6.08e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SERPINE1—stomach cancer	1.65e-06	6.07e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—MTHFR—stomach cancer	1.65e-06	6.07e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.63e-06	5.98e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UMPS—stomach cancer	1.61e-06	5.91e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTT1—stomach cancer	1.6e-06	5.88e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RHOA—stomach cancer	1.6e-06	5.85e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PPARG—stomach cancer	1.6e-06	5.85e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPARG—stomach cancer	1.6e-06	5.85e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.59e-06	5.83e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2A6—stomach cancer	1.58e-06	5.81e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOS3—stomach cancer	1.58e-06	5.79e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKR1C3—stomach cancer	1.54e-06	5.65e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CAV1—stomach cancer	1.54e-06	5.65e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPARG—stomach cancer	1.54e-06	5.64e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOA1—stomach cancer	1.54e-06	5.63e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPP2R1A—stomach cancer	1.54e-06	5.63e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CAV1—stomach cancer	1.53e-06	5.6e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOA1—stomach cancer	1.52e-06	5.58e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CD44—stomach cancer	1.52e-06	5.58e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—stomach cancer	1.51e-06	5.54e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—stomach cancer	1.51e-06	5.52e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ENO1—stomach cancer	1.5e-06	5.51e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.5e-06	5.5e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPARG—stomach cancer	1.5e-06	5.5e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PDHA1—stomach cancer	1.5e-06	5.49e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ECHS1—stomach cancer	1.5e-06	5.49e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—HMOX1—stomach cancer	1.49e-06	5.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—stomach cancer	1.48e-06	5.42e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.48e-06	5.41e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—stomach cancer	1.47e-06	5.4e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPARG—stomach cancer	1.46e-06	5.36e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HMOX1—stomach cancer	1.45e-06	5.33e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—NOS3—stomach cancer	1.45e-06	5.3e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—stomach cancer	1.44e-06	5.3e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—stomach cancer	1.43e-06	5.26e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—stomach cancer	1.43e-06	5.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FADS1—stomach cancer	1.41e-06	5.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMP—stomach cancer	1.41e-06	5.16e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.4e-06	5.15e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—stomach cancer	1.4e-06	5.14e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—stomach cancer	1.38e-06	5.08e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—stomach cancer	1.38e-06	5.07e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NOS3—stomach cancer	1.37e-06	5.03e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NOS3—stomach cancer	1.37e-06	5.03e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—stomach cancer	1.37e-06	5.02e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—stomach cancer	1.37e-06	5.02e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPARG—stomach cancer	1.35e-06	4.96e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—stomach cancer	1.35e-06	4.96e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—stomach cancer	1.35e-06	4.95e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPARG—stomach cancer	1.34e-06	4.92e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CD44—stomach cancer	1.33e-06	4.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NOS3—stomach cancer	1.32e-06	4.85e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—stomach cancer	1.32e-06	4.85e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SREBF2—stomach cancer	1.32e-06	4.84e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—stomach cancer	1.31e-06	4.82e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RORA—stomach cancer	1.3e-06	4.78e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ERCC2—stomach cancer	1.3e-06	4.77e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPP2R1A—stomach cancer	1.29e-06	4.74e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NOS3—stomach cancer	1.29e-06	4.73e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—stomach cancer	1.28e-06	4.68e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ERCC2—stomach cancer	1.27e-06	4.67e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—stomach cancer	1.27e-06	4.65e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—stomach cancer	1.26e-06	4.63e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NOS3—stomach cancer	1.26e-06	4.61e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—stomach cancer	1.25e-06	4.6e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—stomach cancer	1.25e-06	4.6e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HMOX1—stomach cancer	1.25e-06	4.59e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTHFR—stomach cancer	1.22e-06	4.49e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDOB—stomach cancer	1.22e-06	4.48e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—stomach cancer	1.22e-06	4.46e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—stomach cancer	1.21e-06	4.44e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—stomach cancer	1.21e-06	4.43e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—stomach cancer	1.21e-06	4.42e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTHFR—stomach cancer	1.2e-06	4.39e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—stomach cancer	1.18e-06	4.33e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—stomach cancer	1.18e-06	4.32e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—stomach cancer	1.17e-06	4.27e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NOS3—stomach cancer	1.16e-06	4.27e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NOS3—stomach cancer	1.15e-06	4.23e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—stomach cancer	1.15e-06	4.22e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK1—stomach cancer	1.15e-06	4.21e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALOX5—stomach cancer	1.14e-06	4.16e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.13e-06	4.15e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAV1—stomach cancer	1.13e-06	4.14e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—stomach cancer	1.13e-06	4.13e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOA1—stomach cancer	1.13e-06	4.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—DPYD—stomach cancer	1.12e-06	4.1e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—stomach cancer	1.11e-06	4.07e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAV1—stomach cancer	1.1e-06	4.05e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOA1—stomach cancer	1.1e-06	4.04e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HMOX1—stomach cancer	1.1e-06	4.02e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ERCC2—stomach cancer	1.1e-06	4.02e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—stomach cancer	1.09e-06	3.98e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—stomach cancer	1.08e-06	3.95e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—stomach cancer	1.06e-06	3.9e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—stomach cancer	1.06e-06	3.87e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—stomach cancer	1.05e-06	3.84e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—stomach cancer	1.03e-06	3.79e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—stomach cancer	1.03e-06	3.79e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTHFR—stomach cancer	1.03e-06	3.78e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK1—stomach cancer	1.02e-06	3.76e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—stomach cancer	1.02e-06	3.76e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—stomach cancer	1.02e-06	3.74e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—stomach cancer	9.97e-07	3.66e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARG—stomach cancer	9.92e-07	3.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—stomach cancer	9.88e-07	3.62e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2A6—stomach cancer	9.76e-07	3.58e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARG—stomach cancer	9.7e-07	3.56e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—stomach cancer	9.68e-07	3.55e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—stomach cancer	9.64e-07	3.54e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ERCC2—stomach cancer	9.6e-07	3.52e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAV1—stomach cancer	9.5e-07	3.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKR1C3—stomach cancer	9.5e-07	3.48e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOA1—stomach cancer	9.48e-07	3.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO1—stomach cancer	9.26e-07	3.39e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—stomach cancer	9.22e-07	3.38e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.08e-07	3.33e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTHFR—stomach cancer	9.02e-07	3.31e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—stomach cancer	8.92e-07	3.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—stomach cancer	8.89e-07	3.26e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—stomach cancer	8.72e-07	3.2e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NOS3—stomach cancer	8.53e-07	3.13e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARG—stomach cancer	8.35e-07	3.06e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NOS3—stomach cancer	8.34e-07	3.06e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAV1—stomach cancer	8.32e-07	3.05e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOA1—stomach cancer	8.31e-07	3.05e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—stomach cancer	8.22e-07	3.02e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CD44—stomach cancer	8.21e-07	3.01e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—stomach cancer	8.14e-07	2.98e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—stomach cancer	7.87e-07	2.89e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—stomach cancer	7.8e-07	2.86e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—stomach cancer	7.72e-07	2.83e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—stomach cancer	7.72e-07	2.83e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—stomach cancer	7.63e-07	2.8e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—stomach cancer	7.44e-07	2.73e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARG—stomach cancer	7.32e-07	2.68e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—stomach cancer	7.26e-07	2.66e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NOS3—stomach cancer	7.18e-07	2.63e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—stomach cancer	7.07e-07	2.59e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.98e-07	2.56e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—stomach cancer	6.85e-07	2.51e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMOX1—stomach cancer	6.75e-07	2.48e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—stomach cancer	6.58e-07	2.41e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—stomach cancer	6.57e-07	2.41e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—stomach cancer	6.55e-07	2.4e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—stomach cancer	6.49e-07	2.38e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—stomach cancer	6.36e-07	2.33e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NOS3—stomach cancer	6.29e-07	2.31e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—stomach cancer	6.29e-07	2.31e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ERCC2—stomach cancer	5.91e-07	2.17e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—stomach cancer	5.76e-07	2.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTHFR—stomach cancer	5.56e-07	2.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAV1—stomach cancer	5.13e-07	1.88e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOA1—stomach cancer	5.12e-07	1.88e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—stomach cancer	4.8e-07	1.76e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—stomach cancer	4.69e-07	1.72e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARG—stomach cancer	4.51e-07	1.65e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—stomach cancer	4.05e-07	1.49e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—stomach cancer	4.04e-07	1.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NOS3—stomach cancer	3.88e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—stomach cancer	3.55e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—stomach cancer	3.54e-07	1.3e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.18e-07	8e-06	CbGpPWpGaD
